[go: up one dir, main page]

DE60005525D1 - 2-aminotetraline zur behandlung von glaukom - Google Patents

2-aminotetraline zur behandlung von glaukom

Info

Publication number
DE60005525D1
DE60005525D1 DE60005525T DE60005525T DE60005525D1 DE 60005525 D1 DE60005525 D1 DE 60005525D1 DE 60005525 T DE60005525 T DE 60005525T DE 60005525 T DE60005525 T DE 60005525T DE 60005525 D1 DE60005525 D1 DE 60005525D1
Authority
DE
Germany
Prior art keywords
aminotetraline
treating glaucoma
sub
racemic
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60005525T
Other languages
English (en)
Other versions
DE60005525T2 (de
Inventor
Stefano Bongrani
Roberta Razzetti
Paolo Chiesi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chiesi Farmaceutici SpA
Original Assignee
Chiesi Farmaceutici SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farmaceutici SpA filed Critical Chiesi Farmaceutici SpA
Publication of DE60005525D1 publication Critical patent/DE60005525D1/de
Application granted granted Critical
Publication of DE60005525T2 publication Critical patent/DE60005525T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60005525T 1999-07-30 2000-07-26 2-aminotetraline zur behandlung von glaukom Expired - Fee Related DE60005525T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI991713 1999-07-30
IT1999MI001713A IT1313583B1 (it) 1999-07-30 1999-07-30 Derivati 2-amminotetralinici per la terapia del glaucoma.
PCT/EP2000/007184 WO2001008667A2 (en) 1999-07-30 2000-07-26 2-aminotetralin derivatives for the therapy of glaucoma

Publications (2)

Publication Number Publication Date
DE60005525D1 true DE60005525D1 (de) 2003-10-30
DE60005525T2 DE60005525T2 (de) 2004-04-22

Family

ID=11383465

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60005525T Expired - Fee Related DE60005525T2 (de) 1999-07-30 2000-07-26 2-aminotetraline zur behandlung von glaukom

Country Status (17)

Country Link
US (1) US6953813B1 (de)
EP (1) EP1200079B1 (de)
JP (1) JP2003505499A (de)
CN (1) CN1170532C (de)
AT (1) ATE250413T1 (de)
AU (1) AU778148B2 (de)
CA (1) CA2379778A1 (de)
CZ (1) CZ2002358A3 (de)
DE (1) DE60005525T2 (de)
ES (1) ES2207544T3 (de)
HK (1) HK1048594A1 (de)
HU (1) HUP0202098A3 (de)
IT (1) IT1313583B1 (de)
NO (1) NO20020475L (de)
PL (1) PL364794A1 (de)
WO (1) WO2001008667A2 (de)
ZA (1) ZA200200787B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL152751A0 (en) * 2000-05-12 2003-06-24 Chiesi Farma Spa Optically active 2-aminotetralin derivatives, the processes for the preparation thereof and the therapeutical use of pharmaceutical compositions containing them
US20020198209A1 (en) * 2001-05-03 2002-12-26 Allergan Sales Inc. Compositions having enhanced pharmacokinetic characteristics
RU2008122978A (ru) 2005-11-09 2009-12-20 Комбинаторкс, Инкорпорейтед (Us) Способы, композиции и наборы для лечения медицинских состояний
US7829587B2 (en) 2008-01-09 2010-11-09 Allergan, Inc. Substituted 2-aminotetralin derivatives as selective alpha 2B agonist

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA794872B (en) * 1978-09-20 1980-11-26 Schering Corp A phenylalkylaminoethylsalicylamide,its preparation and pharmaceutical compositions containing it
IT1218322B (it) * 1982-06-10 1990-04-12 Chiesi Farma Spa Derivati di 1,2,3,4-tetraidronaftalene,procedimento di preparazione e relative composizioni farmaceutiche
US5236907A (en) * 1988-10-01 1993-08-17 R-Tech Ueno Ltd. Ocular hypotensive agents
US5314916A (en) * 1993-04-19 1994-05-24 Alcon Laboratories, Inc. B2 adrenegic agonists and use thereof in the treatment of glaucoma
IT1275935B1 (it) 1995-03-17 1997-10-24 Chiesi Farma Spa Derivato di aminotetralina per la terapia di malattie cardiovascolari

Also Published As

Publication number Publication date
ITMI991713A1 (it) 2001-01-30
CN1364081A (zh) 2002-08-14
CN1170532C (zh) 2004-10-13
AU778148B2 (en) 2004-11-18
HUP0202098A3 (en) 2003-08-28
ATE250413T1 (de) 2003-10-15
ITMI991713A0 (it) 1999-07-30
CA2379778A1 (en) 2001-02-08
WO2001008667A2 (en) 2001-02-08
DE60005525T2 (de) 2004-04-22
ES2207544T3 (es) 2004-06-01
HK1048594A1 (zh) 2003-04-11
HUP0202098A2 (en) 2002-10-28
EP1200079B1 (de) 2003-09-24
NO20020475L (no) 2002-03-13
AU6829300A (en) 2001-02-19
EP1200079A2 (de) 2002-05-02
CZ2002358A3 (cs) 2002-04-17
ZA200200787B (en) 2003-03-26
US6953813B1 (en) 2005-10-11
PL364794A1 (en) 2004-12-13
IT1313583B1 (it) 2002-09-09
WO2001008667A3 (en) 2001-06-07
NO20020475D0 (no) 2002-01-29
JP2003505499A (ja) 2003-02-12

Similar Documents

Publication Publication Date Title
SE9701144D0 (sv) Novel compounds, their use and preparation
SE9903760D0 (sv) New compounds
ATE383339T1 (de) Amin-derivate zur behandlung von apoptosis
DZ1694A1 (fr) "n-(2-Aminoethyl)-benzothialozones".
SE9601110D0 (sv) Substituted 1,2,3,4-tetrahydronaphthalene derivatives
DE69008142D1 (de) 4-Substituierten Imidazolen zur Senkung des intraokularen Druckes.
DE3888340D1 (de) Verwendung von 1,4-disubstituierten-Piperidinyl-Verbindungen zur Herstellung eines Arzneimittels zur Behandlung von Schlaflosigkeit.
DE69413118D1 (de) Benzolsulfonamid-Derivate zur Behandlung der Blaseninstabilität
DE69525633D1 (de) Chinoxalinderivate und ihre therapeutische verwendbarkeit
DE60005525D1 (de) 2-aminotetraline zur behandlung von glaukom
DE69828197D1 (de) Amidderivate zur behandlung neurodegenerativer erkrankungen der netzhaut
DE69518706D1 (de) Verwendung von Diphenylethanderivaten zur Herstellung eines Arzneimittels zur Behandlung von Glaukom
ATE297926T1 (de) Hexahydropyrazino(1'2':1,6)-pyrido(3,4-b)indole 1,4-dion-derivate zur behandlung von cardiovaskulären erkrankungen und erektionsstörungen
ATE63541T1 (de) N-phenylethylaminoalkyl-benzamide als antiarrhythmische mittel.
ATE88460T1 (de) Verbindungen zur behandlung von harninkontinenz.
ATE100439T1 (de) 2-(2-hydroxy-3-phenoxypropylamino)-ethoxybenzol derivate.
ATE181503T1 (de) Verwendung von idazoxan und derivaten zur herstellung eines arzneimittels zur behandlung von parkinsonismus und seiner evolution
SE9900190D0 (sv) New compounds
ATE293591T1 (de) Neue n-(2-phenyl-3-aminopropyl)naphtamide
ATE250027T1 (de) Azetidincarboxamidderivate zur behandlung von zns-erkrankungen
ATE236634T1 (de) Verwendung von 4-piperidinmethanolderivaten zur behandlung von neuralentwicklungsstörungen
DK347387D0 (da) Amidderivater
DE69619088D1 (de) Quinoxalin-Derivate zur Behandlung von Tinnitus
EP1325918A4 (de) Herzmuskelzellen-apoptose hemmstoffe und behandlung/vorbeugung von herzkrankheiten
ATE186912T1 (de) Carbamoylpyrrolidon-derivate zur behandlung von depressionen und cerebrovasculären störungen

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee